173.13 0.00%

1M-0.35% 1Y +0.03%   Market Closed

Analysts Review about Johnson & Johnson

Market Consensus (11 Analysts)

Buy

Price Target High -

Spread: -

Price Target Average -

Spread: -

Price Target Low -

Spread: -

Johnson & Johnson Among Trending Stocks For Second Week In A Row

2 Top Value Stocks to Buy Right Now

Technical Analyses Trend

Periods

Trend

Resistance

Support

Short Term

Neutral

1,490.96 (761.18%)

1,474.96 (751.94%)

Mid Term

Bullish

167.91 (-3.01%)

165.87 (-4.20%)

Long Term

Bearish

160.93 (-7.05%)

158.65 (-8.36%)

  • 1W
  • 1M
  • 1Y
  • 5Y

Johnson & Johnson Articles

Seeking Alpha

Week 11 MDA Breakout Stocks - March 2021: Short-Term Picks To Give You An Edge

Two new breakout stocks for Week 11 of 2021 with better than 10% short-term upside potential. This past week both DSSI +11.4% and JNCE +27.1% gained more than 10% while the average return to the close for all 4 selections was a gain of +6.09%.

Sentiment: Positive 2021-03-13

The Motley Fool

Is Johnson & Johnson's COVID Vaccine Actually Better Than Pfizer's and Moderna's Vaccines?

Don't jump to any conclusions based on the different vaccines' advisory committee votes.

Sentiment: Neutral 2021-03-13

Forbes

WHO Approves Johnson & Johnson's Covid Vaccine As Developing Countries Lag In Immunizations

The approval greenlights Johnson & Johnson's vaccine to start reaching dozens of low- and middle-income countries.

Sentiment: Positive 2021-03-12

SpStocks Review about Johnson & Johnson

SPS Rank 5th

SPS Note 8.5

SPS Consensus (08 Analysts) Buy

Target Price 650,611.05 USD 375,693.37%

Potentials Excellent

Growth (Revenue) Extremely Poor

Finances Good

Profitability Very Good

Earnings Quality Good

P/E Ratio Excellent

Valuation Overvalued

Fair Value 164.83USD 4.80%

Source

Sentiment

2021-03-12 J&J (JNJ) COVID-19 Vaccine Gets Conditional Approval in Europe

Za

Positive

2021-03-12 Johnson & Johnson's COVID-19 Vaccine Could Threaten Moderna, Novavax

Se

Positive

2021-03-12 How Does Johnson & Johnson's COVID Vaccine Approval Affect Moderna?

Th

Neutral

2021-03-12 7 of the Best Value Stocks on the Market Today

In

Positive

2021-03-11 EU Approves J&J Single-Shot Covid-19 Vaccine As The Bloc's Vaccination Crisis Rumbles On

Fo

Negative

2021-03-11 Consumer Discretionary ETFs to Ride Stimulus & Vaccine Optimism

Za

Positive

2021-03-11 5 Top Blue Chip Stocks to Buy as Dow Breezes Past 32,000

Za

Positive

2021-03-11 Johnson & Johnson Poised To Win European Approval For Its COVID-19 Vaccine

Be

Positive

Johnson & Johnson Overview 30 Nov 2020

Open 173.49

High 174.49

Low 172.48

1 Day Change (Last) -0.53

1 Day Change Percent (Last) 0.00%

Close 173.13

Previous Close 173.66

Volume 0

52 Week High 178.93

52 Week low 130.31

Gross Margin % 65.58%

Net Margin % 65.58%

Total Shares Outstanding 2.63B

Market Capitalization 455.76B

Johnson & Johnson Weight (JNJ) 0.04%

Dividends

Dividends Paid (Last Quarter) 0.00

Dividends Paid (Last Fiscal Year)0.00

Dividends Per Share (Last Quarter) 0.00

Dividends Yield (Last Fiscal Year) 0.00

Dividends Per Share (Last Fiscal Year) 0.00

Income Statement

Net Income (Last Fiscal Year) NA

1 year Revenue revision 89.19B

4 months Revenue revision 30.42B

4 months EPS revision

7 days EPS revision

1 Year Basic Before EPS (Last Fiscal Year)

1 Year Basic EPS Revision (Last Fiscal Year)